Adithya Hande: India’s Silent Killer and a Scientific Breakthrough
Adithya Hande, Head of Clinical Projects at DERBI Foundation, shared a post on LinkedIn:
”India’s Silent Killer — and a Scientific Breakthrough You Need to Know About
Thrombosis-related diseases (like pulmonary embolism, stroke, and DVT) are quietly responsible for millions of hospitalizations and deaths in India each year — especially post-COVID.
Yet, we’re still relying on decades-old anticoagulants with dangerous side effects like internal bleeding and poor patient adherence.
But what if we could prevent clots safely, without disrupting the body’s natural healing?
Scientists at IISc have developed a game-changing nanozyme that mimics antioxidant enzymes — a first-of-its-kind, bleeding-free clot therapy.
This article dives into:
- What makes this science revolutionary
- The current treatment challenges for thrombosis in India
- Market gaps ripe for startup innovation
- Why this could be a deeptech goldmine for healthcare entrepreneurs
Click below to read the full breakdown — from a healthcare innovation lens.”

Stay updated with Hemostasis Today.
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM